×
App Icon
The Standard e-Paper
Home To Bold Columnists
★★★★ - on Play Store
Read on the App

WHO pauses hydroxychloroquine trial due to safety concerns

Anti-malaria drug hydroxychloroquine tablets. [Courtesy]

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.

Get Full Access for Ksh299/Week
Bold Reporting Takes Time, Courage and Investment. Stand With Us.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in